Development of HPV58 type-specific antibodies and detection kit. PMID: 35465823
Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil. PMID: 25793187
Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency. PMID: 33636291
[Expression of the human papillomavirus type 58L1 capsid protein in E.coli and preparation of the HPV58 L1 mouse antiserum]. PMID: 11986714
Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system. PMID: 34890711
L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis. PMID: 27717385
Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae. PMID: 23183918
Characteristics of human papillomavirus infection among females and the genetic variations of HPV18 and HPV58 in Henan province, China. PMID: 36755053
The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae. PMID: 23124750
Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China. PMID: 23372836
Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58. PMID: 27708433
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. PMID: 27147749
HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study. PMID: 35945577
[Carboxyl terminus truncated HPV58 virus L1 protein expressed with baculovirus system and its bioactivity]. PMID: 15968984
[Construction of prophylactic recombinant HPV58-attenuated Shigella vector live vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model]. PMID: 18062891
Phylogeographic analysis of human papillomavirus 58. PMID: 20016974
Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PMID: 21673791
Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model. PMID: 19204831
An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles. PMID: 18691524
Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia. PMID: 23871162
The preparation of human papillomavirus type 58 vaccine and exploring its biological activity and immunogenicity in vitro. PMID: 21738041
Genetic diversity and bioinformatic analysis in the L1 gene of HPV genotypes 31, 33, and 58 circulating in women with normal cervical cytology. PMID: 36959610
Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity. PMID: 31281327
Prevalence of Human Papillomavirus Genotypes in Pterygia from Thai Individuals. PMID: 33736562
Genetic signatures for lineage/sublineage classification of HPV16, 18, 52 and 58 variants. PMID: 33238224
L1 sequence of a new human papillomavirus type-58 variant associated with cervical intraepithelial neoplasia. PMID: 15665981
[Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.]. PMID: 19961800
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus. PMID: 28951471
Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins. PMID: 25203446
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70. PMID: 36316367
A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses. PMID: 34960247
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. PMID: 12050360
Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58. PMID: 20181746
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies. PMID: 20334659
Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies. PMID: 29905865
Prevalence of human papillomavirus types and phylogenetic analysis of HPV-16 L1 variants from Southern India. PMID: 25773853
Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines. PMID: 23722024
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. PMID: 30353680
Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52. PMID: 35246180
T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer. PMID: 20668141
Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types. PMID: 28968993
Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women. PMID: 26113443
Genome sequencing accuracy by RCA-seq versus long PCR template cloning and sequencing in identification of human papillomavirus type 58. PMID: 24410913
Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)-Implications for Pathogenicity and Vaccine Effectiveness. PMID: 36557745
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay. PMID: 21068278
The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptide., PMID:40170153
[The soluble expression and application of human papillomavirus type 58 (HPV58) major capsid protein L1]., PMID:35732612
Development of HPV58 type-specific antibodies and detection kit., PMID:35465823
Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system., PMID:34890711
Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency., PMID:33636291
Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes., PMID:32967963
Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies., PMID:29905865
Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types., PMID:28968993
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus., PMID:28951471
L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis., PMID:27717385
Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58., PMID:27708433
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles., PMID:27147749
Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study., PMID:25999521
Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil., PMID:25793187
Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins., PMID:25203446
Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia., PMID:23871162
Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines., PMID:23722024
Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China., PMID:23372836
Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae., PMID:23183918
The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae., PMID:23124750
Hospital-based prevalence of high-risk cervical HPV types infecting the general population and female sex workers in Huzhou, China., PMID:23044007
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection., PMID:21346041
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay., PMID:21068278
T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer., PMID:20668141
Translational comparison of HPV58 long and short L1 mRNAs in yeast (Saccharomyces cerevisiae) cell-free system., PMID:20541117
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies., PMID:20334659
Phylogeographic analysis of human papillomavirus 58., PMID:20016974
[Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.]., PMID:19961800
Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model., PMID:19204831
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity., PMID:19095032
An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles., PMID:18691524
[Construction of prophylactic recombinant HPV58-attenuated Shigella vector live vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model]., PMID:18062891
[Molecular detection of specific HPV types in Condylomata acuminata]., PMID:16257894
L1 sequence of a new human papillomavirus type-58 variant associated with cervical intraepithelial neoplasia., PMID:15665981
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses., PMID:12050360
[Expression of the human papillomavirus type 58L1 capsid protein in E.coli and preparation of the HPV58 L1 mouse antiserum]., PMID:11986714
For research use only. Not for human or drug use.
